【 微流体生物芯片技术研发公司】Advanced Biomed Inc.（ADVB）美股招股说明书 S-1（2025-07-23首版）（英文版）（258页）.pdf

1、As filed with the United States Securities and Exchange Commission on July 23,2025.Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549 FORM S-1 REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 Advanced Biomed Inc.(Exact name of registrant as specified in its

2、charter)Nevada 8071 87-2177170(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)No.689-85 Xiaodong Road,Yongkang DistrictTainan City,TaiwanTel:886-6-3121716(Address,including zip code,and telephone

3、 number,including area code,of registrants principal executive offices)Cogency Global Inc.122 East 42nd Street,18th FloorNew York,NY 10168(212)947-7200(Name,address,including zip code,and telephone number,including area code,of agent for service)Copies of all communications to:Fang Liu,Esq.VCL Law L

4、LP1945 Old Gallows RoadSuite 260Vienna,VA 22182Telephone:(703)919-7285 Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of thisregistration statement.If any of the securities being registered on this Form are to be offered on a delayed o

5、r continuous basis pursuant to Rule 415 underthe Securities Act of 1933,check the following box:If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,check thefollowing box and list the Securities Act registration statement number of

6、the earlier effective registration statement for the sameoffering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securities Act,check the following box and listthe Securities Act registration statement number of the earlier effective registration statement for the